Silencing the killers: paracrine immune suppression in pancreatic cancer

Adrienne D Cox1, Kenneth P Olive

  • 1Departments of Radiation Oncology and Pharmacology, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. adrienne_cox@med.unc.edu

Cancer Cell
|June 16, 2012
PubMed

Insights

Pancreatic cancers suppress the immune system. Tumor cells secrete GM-CSF, recruiting myeloid-derived suppressor cells to block killer T cells and hinder anti-tumor immunity.

Area of Science:

  • Oncology
  • Immunology
  • Cancer Biology

Background:

  • Pancreatic cancers exhibit significant inflammatory cell infiltration and immune suppression.
  • Understanding the mechanisms of immune evasion in pancreatic ductal adenocarcinoma (PDAC) is critical.

Discussion:

  • Bayne et al. and Pylayeva-Gupta et al. identify Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) as a key mediator in PDAC immune suppression.
  • KRAS-driven tumor cells secrete GM-CSF, which attracts myeloid-derived suppressor cells (MDSCs) into the tumor stroma.

Key Insights:

  • GM-CSF recruits MDSCs to the pancreatic tumor microenvironment.
  • The influx of MDSCs abrogates the immune clearance of tumor cells by cytotoxic T lymphocytes (CTLs).
  • This mechanism highlights a critical pathway for immune evasion in KRAS-mutant pancreatic cancer.

Outlook:

  • Targeting GM-CSF or MDSC recruitment could represent a novel therapeutic strategy for pancreatic cancer.
  • Further research into the interplay between tumor-secreted factors and immune cell infiltration is warranted.
  • Developing immunotherapies that overcome MDSC-mediated suppression may improve patient outcomes.

Related Concept Videos

Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...